Traphagen Investment Advisors’s Avantis US Equity ETF AVUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$130M Sell
1,015,751
-37,993
-4% -$4.68M 9.29% 2
2026
Q1
$117M Sell
1,053,744
-199,706
-16% -$22.9M 9.49% 2
2025
Q4
$140M Buy
1,253,450
+20,025
+2% +$2.21M 11.53% 2
2025
Q3
$134M Buy
1,233,425
+18,287
+2% +$1.92M 11.54% 2
2025
Q2
$123M Buy
1,215,138
+34,596
+3% +$3.24M 11.6% 2
2025
Q1
$109M Buy
1,180,542
+11,186
+1% +$1.09M 11.38% 2
2024
Q4
$113M Buy
1,169,356
+12,358
+1% +$1.21M 11.53% 2
2024
Q3
$110M Buy
1,156,998
+13,442
+1% +$1.23M 11.11% 2
2024
Q2
$103M Buy
1,143,556
+11,174
+1% +$987K 11.2% 2
2024
Q1
$101M Buy
1,132,382
+16,150
+1% +$1.36M 10.81% 2
2023
Q4
$91M Buy
1,116,232
+20,632
+2% +$1.56M 10.68% 2
2023
Q3
$80.3M Buy
+1,095,600
New +$83.2M 10.17% 2

Other funds holding AVUS

Traphagen Investment Advisors's AVUS Position: Q2 2026 in Review

Traphagen Investment Advisors reduced its Avantis US Equity ETF (AVUS) stake by 3.6% in Q2 2026, selling an estimated $4.68M and leaving 1,015,751 shares worth $130M. The position accounts for 9.29% of the portfolio, ranked #2.

Traphagen Investment Advisors first reported a position in AVUS in Q3 2023 and has held it in 12 quarters since. The position peaked at $140M in Q4 2025. 398 funds tracked by Wall St. Rank hold AVUS as of Q2 2026.

  • Traphagen Investment Advisors held 1,015,751 shares of Avantis US Equity ETF worth $130M as of Q2 2026.
  • Traphagen Investment Advisors sold 37,993 Avantis US Equity ETF shares in Q2 2026, an estimated $4.68M.
  • Avantis US Equity ETF made up 9.29% of Traphagen Investment Advisors's portfolio in Q2 2026, its #2 holding.
  • Traphagen Investment Advisors first reported a position in Avantis US Equity ETF in Q3 2023 and has held it in 12 quarters since.
  • Traphagen Investment Advisors's Avantis US Equity ETF position peaked at $140M in Q4 2025.
  • 398 funds tracked by Wall St. Rank held Avantis US Equity ETF as of Q2 2026.

Based on Traphagen Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.